ORIGINAL RESEARCH
Published on 09 Jun 2025
Trained autologous cytotoxic T-cells derived from PBMCs or splenocytes for immunotherapy of neuroblastoma
doi 10.3389/fimmu.2025.1546441
- 2,937 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel Clinical and Translational Insights in Cell Therapies for Cancer
Novel Clinical and Translational Insights in Cell Therapies for Cancer
9,055
Total downloads
39k
Total views and downloads
Articles
REVIEW
Published on 21 May 2025
Emerging immunotherapy and tumor microenvironment for advanced sarcoma: a comprehensive review
doi 10.3389/fimmu.2025.1507870
- 3,916 views
- 3 citations
ORIGINAL RESEARCH
Published on 28 Apr 2025
Development and validation of an ARID1A-related immune genes risk model in evaluating prognosis and immune therapeutic efficacy for gastric cancer patients: a translational study
doi 10.3389/fimmu.2025.1541491
- 2,461 views
- 1 citation
REVIEW
Published on 10 Feb 2025
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
doi 10.3389/fimmu.2025.1515748
- 6,162 views
- 10 citations
ORIGINAL RESEARCH
Published on 26 Nov 2024
Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model
doi 10.3389/fimmu.2024.1507218
- 3,516 views
- 3 citations
SYSTEMATIC REVIEW
Published on 16 Oct 2024
Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis
doi 10.3389/fimmu.2024.1454427
- 10,966 views
- 11 citations
CASE REPORT
Published on 30 Jul 2024
Case report: Dual-targeted BCMA and CS1 CAR-T-cell immunotherapy in recurrent and refractory extramedullary multiple myeloma
doi 10.3389/fimmu.2024.1422478
- 3,062 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Vaccines and Molecular Therapeutics
T Cell Biology
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore